Home » Sanofi Pasteur Presents Phase III Data for Investigational Quadrivalent Influenza Vaccine
Sanofi Pasteur Presents Phase III Data for Investigational Quadrivalent Influenza Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, presented an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine.
4-Traders
4-Traders
Upcoming Events
-
07May
-
14May
-
30May